Abstract:This report describes the synthesis of two cyclic RGD (Arg-Gly-Asp) conjugates, HYNIC-2PEG(4)-dimer (HYNIC = 6-hydrazinonicotinyl; 2PEG(4)-dimer = E[PEG(4)-c(RGDfK)](2); and PEG(4) = 15-amino-4,7,10,13-tetraoxapentadecanoic acid) and HYNIC-3PEG(4)-dimer (3PEG(4)-dimer = PEG(4)-E[PEG(4)-c(RGDfK)](2)), and evaluation of their Tc-99m complexes [Tc-99m(HYNIC-2PEG(4)-dimer)(tricine)(TPPTS)] (Tc-99m-2PEG(4)-dimer: TPPTS = trisodium triphenylphosphine-3,3',3 ''-trisulfonate) and [Tc-99m(HYNIC-3PEG(4)-dimer)(tricine)(TPPTS)] (Tc-99m-3PEG(4)-dimer) as novel radiotracers for imaging integrin alpha(v)beta(3) expression in athymic rude mice bearing U87MG glioma and MDA-MB-435 breast cancer xenografts. The integrin alpha(v)beta(3) binding affinities of RGD peptides were determined by competitive displacement of I-125-c(RGDyK) on U87MG glioma cells. It was found that the two PEG4 linkers between RGD motifs in HYNIC-2PEG(4)-dimer (IC50 = 2.8 +/- 0.5 nM) and HYNIC-3PEG(4)-dimer (IC50 = 2.4 +/- 0.7 nM) are responsible for their higher integrin alpha(v)beta(3) binding affinity than that of HYNIC-PEG(4)-dimer (PEG(4)-dimer = PEG(4)-E[c(RGDfK)](2); IC50 = 7.5 +/- 2.3 nM). Addition of extra PEG(4) linker in HYNIC-3PEG(4)-dimer has. little impact on integrin alpha(v)beta(3) binding affinity. Tc-99m-2PEG(4)-dimer and Tc-99m-3PEG(4)-dimer were prepared in high yield with >95% radiochemical purity and the specific activity of > 10 CI/mu mol. Biodistribution :studies clearly demonstrated that PEG(4) linkers are particularly useful for improving the tumor uptake and clearance kinetics of 99mTc-2PEG4-dimer and Tc-99m-3PEG(4)-dimer from noncancerous organs. It was also found that there was a linear relationship between the tumor size and radiotracer tumor uptake expressed as %ID (percentage of the injected dose) in U87MG glioma and MDA-MB-435 breast tumor models. The blocking experiment showed that the tumor uptake of Tc-99m-2PEG(4)-dimer is integrin alpha(v)beta(3)-mediated. In the metabolism study, Tc-99m-2PEG(4)-dimer had high metabolic stability during its excretion from renal and hepatobiliary routes. Tc-99m-3PEG(4)-dimer also remained intact during thee excretion from the renal route, but, had similar to 30% metabolism during the excretion from the hepatobiliary route. Planar imaging studies in U87MG glioma and MDA-MB-435 breast tumor models showed that the tumors of similar to 5 mm in diameter could be readily visualized with excellent contrast. Thus, Tc-99m-3PEG(4)-dimer is a very promising radiotracer for the early detection of integrin alpha(v)beta(3)-positive tumors, and may have the potential for noninvasive monitoring of tumor growth or treatment efficacy.

Gd-EDDA/HYNIC-RGD As an MR Molecular Probe Imaging Integrin Alphanubeta3 Receptor-Expressed Tumor-Mr Molecular Imaging of Angiogenesis.

Preliminary study of molecular imaging of human hepatocellular carcinoma xenograft with Gd-based MR probe containing arginine-glycine-aspartic acid chelate

Preliminary Study of Molecular Imaging of Human Hepatoceilular Carcinoma Xenoggaft with Gd-based MR Probe Containiug Arginine-Glycine-aspartic Acid Chelate

Molecular Imaging of Tumor Angiogenesis Using Rgd-Labeled Iron Oxide Nanoparticles

188Re-Labeled GX1 Dimer As a Novel Dual-Functional Probe Targeting TGM2 for Imaging and Antiangiogenic Therapy of Gastric Cancer

Tumor uptake of the RGD dimeric probe99mTc-G3-2P 4-RGD2 is correlated with integrin αv/β 3 expressed on both tumor cells and neovasculature

Imaging of 99Tcm-Labeled New Cyclic RGDfK Dimer in Nude Mice Bearing U87MG Human Glioma Xenografts

A New Cyclic RGD Peptide Dimer for Integrin Αvβ3 Imaging.

Evaluation of a 99Mtc-Labeled Cyclic RGD Tetramer for Noninvasive Imaging Integrin Αvβ3-Positive Breast Cancer

A Targeted Nanoglobular Contrast Agent from Host-Guest Self-Assembly for MR Cancer Molecular Imaging.

Noninvasive Imaging of Tumor Integrin Expression Using 18 F-labeled RGD Dimer Peptide with PEG 4 Linkers

131)I Labeling and Bioactivity Evaluation of a Novel RGD Dimer Targeted to Integrin Αvβ3 Receptor

Imaging of 99Tcm-Cycllc RGD Tetramer in Nude Mice Bearing U87MG Human Glioma Xenografts

A Novel Integrinαvβ3-Targeted Isodgr Probe for SPECT/CT Imaging of Glioma

Improving Tumor Uptake and Excretion Kinetics of 99Mtc-Labeled Cyclic Arginine-Glycine-aspartic (RGD) Dimers with Triglycine Linkers.

Improving Tumor-Targeting Capability and Pharmacokinetics of 99Mtc-Labeled Cyclic RGD Dimers with PEG4 Linkers

Biodistribution in Healthy KM Mice and Micro PET/CT Imaging in U87MG Tumor-Bearing Nude Mice of a New 18F-Labeled Cyclic RGD Dimer

Design, Activity Determination and 99mtc Labeling of Cyclic RGD Dimer for Targeting Integrin Αvβ3

18F Labeled RGD‐A7R Peptide for Dual Integrin and VEGF‐targeted Tumor Imaging in Mice Bearing U87MG Tumors

Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner.

Molecular Imaging and Preclinical Studies of Radiolabeled Long-Term RGD Peptides in U-87 MG Tumor-Bearing Mice